Nanobiotix

Identification

Instrument name
NANOBIOTIX
Symbol
NANO
ISIN code
FR0011341205
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description

Nanobiotix develops nanoparticle-based technologies used in safe and non-invasive cancer treatments. Nanobiotix’s technology, NanoXray, seeks to improve the efficacy of radiation therapy by limiting healthy tissues’ tolerance to the radiations that must pass through them to reach tumor tissues.
Source: Cofisem

Website address
http://www.nanobiotix.com

Operation

IPO date
Mon 29/10/2012
IPO type

Initial Public Offering

IPO price
Indicative price range for the Offer: EUR 5.04 - EUR 6.16 (the "Offering Price")
IPO type
Initial Public offering
Catégorie
IPO
Operation calendar

23 October 2012 Listing date
29 October 2012 First Trading date